Skip to main content

Table 3 Patient medication

From: First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease

 

Patient no.

Pre-FUS l-dopa equivalents (mg/day)

3 months post-FUS l-dopa equivalents (mg/day)

Pre-FUS dopamine agonists (mg/day)

3 months post-FUS dopamine agonists (mg/day)

Group 1

1

1,000

1,000

Ropinirol: 3

Ropinirol: 3

Amantadine: 300

Amantadine: 300

Biperiden: 4

Biperiden: 4

2

800

800

-

-

3

300

-

-

-

4

600

600

Biperiden: 6

-

Group 2

5

1,000

-

-

-

6

1,000

-

-

-

7

1,200

600

Ropinirol: 2

Ropinirol: 2

8

-

-

-

-

9

600

1,000

Rotigotine: 8

-

10

1,000

600

Ropinirol: 10

-

11

-

-

Amantadine: 1,000

Amantadine: 600

12

800

800

Ropinirol: 4

Ropinirol: 4

13

800

500

Amantadine: 300

Amantadine: 300

Entacapone: 1,600

Entacapone: 1,000

Mean

 

827

536

  
  1. Pre- and postoperative antiparkinsonian medication. Patients 8 and 11 had stopped their l-dopa intake long before the intervention. Mean intakes of l-dopa equivalents were calculated over 11 patients.